Myriad Genetics Applauds New Expanded Carrier Screening Practice Guidelines from NSGC March 1, 2023 SALT LAKE CITY, March 01, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today anno... Continue Reading